文献速递腹部CT

联合临床指标与能谱CT碘浓度预测胃癌肝转移的初步研究

Combination of clinical and spectral-CT iodine concentration for predicting liver metastasis in gastric cancer: a preliminary study.
PubMed 文献 · Abdom Radiol (NY) · 2024-05-15

回顾性分析80例胃腺癌手术切除患者的临床与能谱CT数据,按有无肝转移分组,测量各期碘图肿瘤最大层面的碘浓度(IC)和标准化碘浓度(nIC)。肝转移组CA125、CEA及动脉期、静脉期、延迟期IC和nIC均显著高于非转移组(均p<0.05)。静脉期nIC(nICVP)预测胃癌肝转移的AUC为0.846,临床指标联合nICVP模型的AUC为0.897,诊断准确性最佳。

要点

  • nICVP预测胃癌肝转移AUC 0.846,为各IC/nIC参数中表现最优者。
  • 临床指标联合nICVP模型AUC 0.897,预测准确性高于单一nICVP。
  • 肝转移组CA125、CEA及动脉期、静脉期、延迟期IC和nIC均显著高于非转移组(均p<0.05)。

核心结论

  • nICVP对预测胃癌肝转移的诊断效能最佳,临床指标联合nICVP模型可提高该情况的预测准确性。

研究设计与样本

  • 回顾性分析80例接受手术切除的胃腺癌患者的临床与能谱CT数据,按有无肝转移分为转移组与非转移组,在各期碘图肿瘤最大层面手动勾画ROI,采用logistic回归构建包含组间差异有统计学意义参数的全部临床指标(CI)模型和临床指标-能谱CT碘浓度(CI-Spectral CT-IC)模型,以ROC曲线评估模型准确性。

诊断标准与关键数值

  • nICVP预测胃癌肝转移的AUC为0.846,在全部IC和nIC参数中表现良好。
  • 临床指标联合nICVP模型预测胃癌肝转移的AUC为0.897,诊断准确性最佳。
  • 肝转移组CA125、CEA及动脉期、静脉期、延迟期IC和nIC均显著高于非转移组(均p<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: This study aimed to determine the diagnostic efficacy of various indicators and models for the prediction of gastric cancer with liver metastasis.

METHODS: Clinical and spectral computed tomography (CT) data from 80 patients with gastric adenocarcinoma who underwent surgical resection were retrospectively analyzed. Patients were divided into metastatic and non-metastatic groups based on whether or not to occur liver metastasis, and the region of interest (ROI) was measured manually on each phase iodine map at the largest level of the tumor. Iodine concentration (IC), normalized iodine concentration (nIC), and clinical data of the primary gastric lesions were analyzed. Logistic regression analysis was used to construct the clinical indicator (CI) and clinical indicator-spectral CT iodine concentration (CI-Spectral CT-IC) Models, which contained all of the parameters with statistically significant differences between the groups. Receiver operating characteristic (ROC) curves were constructed to evaluate the accuracy of the models.

RESULTS: The metastatic group showed significantly higher levels of Cancer antigen125 (CA125), carcinoembryonic antigen (CEA), IC, and nIC in the arterial phase, venous phase, and delayed phase than the non-metastatic group (all p < 0.05). Normalized iodine concentration Venous Phase (nICVP) exhibited a favorable performance among all IC and nIC parameters for forecasting gastric cancer with liver metastasis (area under the curve (AUC), 0.846). The combination model of clinical data with significant differences and nICVP showed the best diagnostic accuracy for predicting liver metastasis from gastric cancer, with an AUC of 0.897.

CONCLUSION: nICVP showed the best diagnostic efficacy for predicting gastric cancer with liver metastasis. Clinical Indicators-normalized ICVP model can improve the prediction accuracy for this condition.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. She Y, Liu X, Liu H, et al. Combination of clinical and spectral-CT iodine concentration for predicting liver metastasis in gastric cancer: a preliminary study. Abdom Radiol (NY). 2024. PMID: 38744700. doi:10.1007/s00261-024-04346-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。